CHRONIC MYELOGENOUS LEUKEMIA

Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA trials appear

Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 3 Completed 6 Terminated 1

New hope for hard-to-treat leukemia: experimental drug enters final testing phase

Disease control Not yet recruiting

This study tests a new drug called TGRX-678 in people with chronic myeloid leukemia (CML) whose cancer has stopped responding to or caused side effects from at least three prior treatments. About 180 adults will receive either TGRX-678 or another standard drug chosen by their doc…

Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA

Phase: PHASE3 • Sponsor: Shenzhen TargetRx Co., Ltd. • Aim: Disease control

Last updated May 06, 2026 16:03 UTC

CHRONIC MYELOGENOUS LEUKEMIA

Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA trials appear

New hope for hard-to-treat leukemia: experimental drug enters final testing phase